[Analysis of RF ablation treatment on quality of life in patients with cardiac arrhythmias].
RF ablation is an acknowledged method of treatment for many arrhythmias. During the ablation procedure the cause of the arrhythmia is eliminated, which results in resolution of cardiac arrhythmia and related clinical manifestations and therefore removes restrictions in the functioning of the patient, which were associated with the presence of arrhythmias. Was to assess quality of life in patients undergoing RF ablation due to atrioventricular nodal reciprocating tachycardia--VNRT, atrioventricular reciprocating tachycardia -AVRT and ventricular ectopic beats --EB's using the SF-36 questionnaire, DASI and Manolis. MMATERIAL AND METHODS The study included 81 patients (56 women and 25 men), who had undergone the RF abla-ion due to AVRT (24 patients), AVNRT (30 patients) or VEB (27 patients). Qual-ty of life was assessed using three questionnaires: the SF-36, DASI and Manolis that patient completed twice: on admission to hospital and after 6 months after ablation. RRESULTS The study showed im-rovement in all scales in the total study population. Subgroup analysis revealed that for each of the group score increased after ablation. The greatest improvement in scores (the biggest difference after-before) in the SF-36 was observed in patients with VEB. Our study found that the greatest improvement in quality of life after ab-ation in patients with a baseline larg-st number of additional ventricular beats (high negative correlation coef-icient -0.77; p <0 .0001 between point difference (after-before ablation) in the SF-36 questionnaire and the reduction of the amount of VEB's). There was no differences observed in improve-ent between patients with AVRT and AVNRT for the SF-36. CoONCLUSIONS Treatment of arrhyth-ias using RF ablation significantly improves the quality of life in patients with cardiac arrhythmias: AVNRT, AVRT, VEB. The largest improvement in quality of life refers to patients with VEBs. Among patients with VEB the greatest benefit had patients with baseline highest amount of ventricle extrasystoles.